Litcius/Paper detail

Genomic mutations and changes in protein secondary structure and solvent accessibility of SARS-CoV-2 (COVID-19 virus)

Thanh Thi Nguyen, Pubudu N. Pathirana, Thin Nguyen, Quoc Viet Hung Nguyen, Asim Bhatti, Dinh C. Nguyen, Dung T. Nguyen, Ngoc Duy Nguyen, Douglas Creighton, Mohamed Abdelrazek

2021Scientific Reports115 citationsDOIOpen Access PDF

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly pathogenic virus that has caused the global COVID-19 pandemic. Tracing the evolution and transmission of the virus is crucial to respond to and control the pandemic through appropriate intervention strategies. This paper reports and analyses genomic mutations in the coding regions of SARS-CoV-2 and their probable protein secondary structure and solvent accessibility changes, which are predicted using deep learning models. Prediction results suggest that mutation D614G in the virus spike protein, which has attracted much attention from researchers, is unlikely to make changes in protein secondary structure and relative solvent accessibility. Based on 6324 viral genome sequences, we create a spreadsheet dataset of point mutations that can facilitate the investigation of SARS-CoV-2 in many perspectives, especially in tracing the evolution and worldwide spread of the virus. Our analysis results also show that coding genes E, M, ORF6, ORF7a, ORF7b and ORF10 are most stable, potentially suitable to be targeted for vaccine and drug development.

Topics & Concepts

VirusGenomeCoronavirusBiologyMutationPandemicComputational biologyCoding regionPoint mutationCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)GeneVirologyProtein secondary structureGeneticsProtein structure predictionProtein structureInfectious disease (medical specialty)MedicineDiseasePathologyBiochemistrySARS-CoV-2 and COVID-19 Researchvaccines and immunoinformatics approachesCRISPR and Genetic Engineering
Genomic mutations and changes in protein secondary structure and solvent accessibility of SARS-CoV-2 (COVID-19 virus) | Litcius